Ghosh Anirvan

Chief Executive Officer, DirectorUnity Biotechnology, Inc. (UBX) · full profile →Form 4 · filed May 12, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
0 non-derivative · 9 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2023Grant(A)57K$057K
May 11, 2023Disposed to issuer(D)57K$00
May 11, 2023Grant(A)29K$029K
May 11, 2023Disposed to issuer(D)29K$00
May 11, 2023Grant(A)15K$015K
May 11, 2023Grant(A)25K$025K
May 11, 2023Disposed to issuer(D)25K$00
May 11, 2023Grant(A)135K$2.77$374K135K
May 11, 2023Disposed to issuer(D)15K$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-012900) within minutes of acceptance. Every field above traces to the original document. Verify it directly: